iShares Neuroscience and Healthcare ETF (IBRN)
$32.55
▼ -0.31 (-0.95%)
1-day change
$32.55 – $40.70
52-week range
-0.04%
Premium / Discount
Aug. 24, 2022
Inception
Net flows (30d): +$0 Estimated from creation/redemption of shares outstanding
Top 10 holdings weight45.74%
Effective number of positions31.6
Positions above 1%30
Net assets
$7.5M
Holdings
80
As of
Sept. 10, 2026
Expense ratio
0.47%
IBRN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -17.50% | ▼ -17.50% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -18.14% | ▼ -18.14% |
Volatility 1Y·
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jul 2026)
+$0
Quarter ending Jul 2026
+$0
Trailing 12 months
+$0
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 80 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES | PRAX | 5.24 | ≈$391K | 1,157 | 74006W207 | 0.005785 | EQUITY | USD |
| DIANTHUS THERAPEUTICS INC | DNTH | 5.04 | ≈$377K | 3,652 | 252828108 | 0.01826 | EQUITY | USD |
| SCHOLAR ROCK HOLDING | SRRK | 4.94 | ≈$369K | 6,638 | 80706P103 | 0.03319 | EQUITY | USD |
| ACADIA PHARMACEUTICALS | ACAD | 4.92 | ≈$368K | 13,265 | 004225108 | 0.06633 | EQUITY | USD |
| XENON PHARMACEUTICALS | XENE | 4.47 | ≈$334K | 5,685 | 98420N105 | 0.02843 | EQUITY | USD |
| ARROWHEAD PHARMACEUTICALS | ARWR | 4.45 | ≈$332K | 4,021 | 04280A100 | 0.02011 | EQUITY | USD |
| ARGENX SE ADR | ARGX | 4.34 | ≈$324K | 330 | 04016X101 | 0.00165 | EQUITY | USD |
| BIOGEN | BIIB | 4.34 | ≈$324K | 1,505 | 09062X103 | 0.007525 | EQUITY | USD |
| ALKERMES | ALKS | 4.24 | ≈$316K | 6,870 | IE00B56GVS15 | 0.03435 | EQUITY | USD |
| NEUROCRINE BIOSCIENCES | NBIX | 3.75 | ≈$280K | 1,793 | 64125C109 | 0.008965 | EQUITY | USD |
| PTC THERAPEUTICS | PTCT | 3.74 | ≈$279K | 4,145 | 69366J200 | 0.02073 | EQUITY | USD |
| AXSOME THERAPEUTICS | AXSM | 3.57 | ≈$267K | 1,265 | 05464T104 | 0.006325 | EQUITY | USD |
| EDGEWISE THERAPEUTICS | EWTX | 3.53 | ≈$264K | 6,153 | 28036F105 | 0.03077 | EQUITY | USD |
| DENALI THERAPEUTICS | DNLI | 3.34 | ≈$249K | 11,666 | 24823R105 | 0.05833 | EQUITY | USD |
| DYNE THERAPEUTICS | DYN | 2.55 | ≈$190K | 10,352 | 26818M108 | 0.05176 | EQUITY | USD |
| SK BIOPHARMACEUTICALS LTD | 326030 | 2.55 | ≈$190K | 3,060 | KR7326030004 | 0.0153 | EQUITY | USD |
| SUPERNUS PHARMACEUTICALS | SUPN | 2.38 | ≈$178K | 4,269 | 868459108 | 0.02135 | EQUITY | USD |
| AXOGEN | AXGN | 2.27 | ≈$169K | 4,054 | 05463X106 | 0.02027 | EQUITY | USD |
| SAREPTA THERAPEUTICS | SRPT | 2.18 | ≈$163K | 7,938 | 803607100 | 0.03969 | EQUITY | USD |
| H. LUNDBECK CLASS B | HLUN B | 1.93 | ≈$144K | 21,005 | DK0061804770 | 0.105 | EQUITY | USD |
| BIOHAVEN | BHVN | 1.68 | ≈$126K | 9,836 | VGG1110E1079 | 0.04918 | EQUITY | USD |
| NEUREN PHARMACEUTICALS | NEU | 1.66 | ≈$124K | 8,580 | NZNEUE0001S8 | 0.0429 | EQUITY | USD |
| BIOARCTIC CLASS B | BIOA B | 1.51 | ≈$113K | 3,341 | SE0010323311 | 0.01671 | EQUITY | USD |
| RAPPORT THERAPEUTICS | RAPP | 1.30 | ≈$97K | 2,230 | 75383L102 | 0.01115 | EQUITY | USD |
| TAYSHA GENE THERAPIES | TSHA | 1.29 | ≈$96K | 18,665 | 877619106 | 0.09333 | EQUITY | USD |
| IDORSIA N LTD | IDIA | 1.15 | ≈$86K | 13,897 | CH0363463438 | 0.06949 | EQUITY | USD |
| INTEGRA LIFESCIENCES HOLDINGS | IART | 1.09 | ≈$81K | 5,220 | 457985208 | 0.0261 | EQUITY | USD |
| ALTO NEUROSCIENCE INC | ANRO | 1.04 | ≈$78K | 2,461 | 02157Q109 | 0.01231 | EQUITY | USD |
| LB PHARMACEUTICALS INC | LBRX | 1.01 | ≈$75K | 1,628 | 50180M108 | 0.00814 | EQUITY | USD |
| ONCOLYS BIOPHARMA INC | 4588 | 1.01 | ≈$75K | 2,000 | JP3202170001 | 0.01 | EQUITY | USD |
| DYNAVOX GROUP | DYVOX | 0.79 | ≈$59K | 7,757 | SE0017105620 | 0.03879 | EQUITY | USD |
| SOLID BIOSCIENCES INC | SLDB | 0.74 | ≈$56K | 6,132 | 83422E204 | 0.03066 | EQUITY | USD |
| MEDINCELL SA | MEDCL | 0.62 | ≈$46K | 1,829 | FR0004065605 | 0.009145 | EQUITY | USD |
| ANNEXON | ANNX | 0.62 | ≈$46K | 11,173 | 03589W102 | 0.05587 | EQUITY | USD |
| CERIBELL | CBLL | 0.60 | ≈$45K | 1,929 | 15678C102 | 0.009645 | EQUITY | USD |
| DESIGN THERAPEUTICS | DSGN | 0.58 | ≈$44K | 2,953 | 25056L103 | 0.01477 | EQUITY | USD |
| BRIGHT MINDS BIOSCIENCES | DRUG | 0.52 | ≈$39K | 593 | 10919W405 | 0.002965 | EQUITY | USD |
| NEUROGENE | NGNE | 0.48 | ≈$36K | 986 | 64135M105 | 0.00493 | EQUITY | USD |
| OVID THERAPEUTICS | OVID | 0.46 | ≈$34K | 13,036 | 690469101 | 0.06518 | EQUITY | USD |
| CAPRICOR THERAPEUTICS | CAPR | 0.46 | ≈$34K | 4,102 | 14070B309 | 0.02051 | EQUITY | USD |
| PROTHENA PLC | PRTA | 0.44 | ≈$33K | 3,678 | IE00B91XRN20 | 0.01839 | EQUITY | USD |
| BENITEC BIOPHARMA INC | BNTC | 0.43 | ≈$32K | 2,641 | 08205P209 | 0.01321 | EQUITY | USD |
| BRAINSWAY ADR REPRESENTING LTD | BWAY | 0.43 | ≈$32K | 2,298 | 10501L106 | 0.01149 | EQUITY | USD |
| REGENXBIO | RGNX | 0.42 | ≈$31K | 3,665 | 75901B107 | 0.01833 | EQUITY | USD |
| RELMADA THERAPEUTICS INC | RLMD | 0.39 | ≈$29K | 7,221 | 75955J402 | 0.03611 | EQUITY | USD |
| NEUROPACE | NPCE | 0.38 | ≈$29K | 2,057 | 641288105 | 0.01029 | EQUITY | USD |
| CLEARPOINT NEURO INC | CLPT | 0.38 | ≈$28K | 2,096 | 18507C103 | 0.01048 | EQUITY | USD |
| SANBIO LTD | 4592 | 0.37 | ≈$27K | 4,500 | JP3336750009 | 0.0225 | EQUITY | USD |
| ZYLOX-TONBRIDGE MEDICAL TECH H | 2190 | 0.36 | ≈$27K | 10,500 | CNE100004JD2 | 0.0525 | EQUITY | USD |
| MICROPORT NEUROTECH CORP | 2172 | 0.34 | ≈$26K | 25,000 | KYG6083E1098 | 0.125 | EQUITY | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Sector breakdown
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Sept. 10, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01838 → -0.01914 (4.1%) |
| Sept. 10, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03826 → 0.03813 (-0.3%) |
| Sept. 8, 2026 | Exited | ETD_USD | Position exited — was 0.000195 units/share |
| Sept. 8, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01616 → -0.01838 (13.7%) |
| Sept. 8, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03798 → 0.03826 (0.7%) |
| Sept. 4, 2026 | New | ETD_USD | New position — 0.000195 units/share |
| Sept. 4, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01511 → -0.01616 (7.0%) |
| Sept. 4, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03714 → 0.03798 (2.3%) |
| Sept. 3, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01036 → -0.01511 (45.7%) |
| Sept. 3, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03798 → 0.03714 (-2.2%) |
| Sept. 2, 2026 | Increased | USD — USD CASH | Units/share: -0.01164 → -0.01036 (-11.0%) |
| Sept. 2, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.0383 → 0.03798 (-0.8%) |
| Sept. 1, 2026 | Trimmed | 4588 — ONCOLYS BIOPHARMA INC | Units/share: 0.0105 → 0.01 (-4.8%) |
| Sept. 1, 2026 | Increased | JPY — JPY CASH | Units/share: 0.07269 → 2.217 (2950.5%) |
| Sept. 1, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01073 → -0.01164 (8.5%) |
| Sept. 1, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03912 → 0.0383 (-2.1%) |
| Aug. 28, 2026 | Increased | KRW — KRW CASH | Units/share: 7.148 → 7.737 (8.2%) |
| Aug. 28, 2026 | Trimmed | USD — USD CASH | Units/share: -0.008935 → -0.01073 (20.1%) |
| Aug. 28, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03891 → 0.03912 (0.5%) |
| Aug. 27, 2026 | Increased | USD — USD CASH | Units/share: -0.00905 → -0.008935 (-1.3%) |
| Aug. 26, 2026 | Trimmed | USD — USD CASH | Units/share: -0.00869 → -0.00905 (4.1%) |
| Aug. 26, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03885 → 0.03891 (0.2%) |
| Aug. 25, 2026 | Increased | USD — USD CASH | Units/share: -0.00908 → -0.00869 (-4.3%) |
| Aug. 24, 2026 | Trimmed | USD — USD CASH | Units/share: -0.00723 → -0.00908 (25.6%) |
| Aug. 21, 2026 | Trimmed | SEK — SEK CASH | Units/share: 0.008715 → 0.00868 (-0.4%) |
| Aug. 21, 2026 | Trimmed | USD — USD CASH | Units/share: -0.006825 → -0.00723 (5.9%) |
| Aug. 21, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03953 → 0.03885 (-1.7%) |
| Aug. 20, 2026 | Increased | USD — USD CASH | Units/share: -0.00779 → -0.006825 (-12.4%) |
| Aug. 20, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.04049 → 0.03953 (-2.4%) |
| Aug. 19, 2026 | Trimmed | USD — USD CASH | Units/share: -0.007685 → -0.00779 (1.4%) |
| Aug. 19, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.04038 → 0.04049 (0.3%) |
| Aug. 18, 2026 | Trimmed | USD — USD CASH | Units/share: -0.000895 → -0.007685 (758.7%) |
| Aug. 18, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.0359 → 0.04038 (12.4%) |
| Aug. 17, 2026 | Trimmed | USD — USD CASH | Units/share: -0.000645 → -0.000895 (38.8%) |
| Aug. 14, 2026 | Increased | USD — USD CASH | Units/share: -0.00445 → -0.000645 (-85.5%) |
| Aug. 14, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.03521 → 0.0359 (2.0%) |
| Aug. 13, 2026 | Increased | USD — USD CASH | Units/share: -0.01557 → -0.00445 (-71.4%) |
| Aug. 13, 2026 | Trimmed | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.04669 → 0.03521 (-24.6%) |
| Aug. 12, 2026 | Trimmed | USD — USD CASH | Units/share: -0.01526 → -0.01557 (2.0%) |
| Aug. 12, 2026 | Increased | XTSLA — BLK CSH FND TREASURY SL AGENCY | Units/share: 0.04629 → 0.04669 (0.9%) |
| Aug. 11, 2026 | Increased | USD — USD CASH | Units/share: -0.01551 → -0.01526 (-1.6%) |
Dividends 4 payments
0.98%TTM yield
$0.32TTM payout / share
Annual
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 16, 2025 | $0.3200 |
| Dec. 17, 2024 | $0.1010 |
| Dec. 20, 2023 | $0.0060 |
| June 7, 2023 | $0.0080 |
Institutional owners (13F) 6 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | $825,331 | 57.79% | 21,257 | Shares | June 30, 2026 |
| BlackRock, Inc. | $582,395 | 40.78% | 15,000 | Shares | June 30, 2026 |
| UBS Group AG | $7,726 | 0.54% | 199 | Shares | June 30, 2026 |
| CWM, LLC | $5,372 | 0.38% | 163 | Shares | March 31, 2026 |
| ASSETMARK, INC | $3,883 | 0.27% | 100 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $3,421 | 0.24% | 88 | Shares | June 30, 2026 |